Scientists track side effects of stronger flu shot for seniors

NCT ID NCT06694025

Not yet recruiting ⭐️ VACCINE ⭐️ Sponsor: Sanofi Source: ClinicalTrials.gov ↗

Summary

This study aims to monitor the safety of a high-dose flu vaccine (Efluelda Tetra) in adults aged 65 and older in South Korea. It will track any side effects or reactions that occur in the month following vaccination under normal doctor's office conditions. The goal is to gather real-world safety information after the vaccine has been approved for use.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLUENZA (HEALTHY VOLUNTEERS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Investigational Site Number : 001

    Seoul, Seoul-teukbyeolsi, 07441, South Korea

Conditions

Explore the condition pages connected to this study.